Related Experiment Video
Updated: Dec 9, 2025

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects
Yuta Yoshino1, Bhaskar Roy1, Yogesh Dwivedi2
1Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Abstract:
Altered synaptic plasticity is often associated with major depressive disorder (MDD). Disease-associated changes in synaptic functions are tightly correlated with altered microRNA (miRNA) expression. Here, we examined the role of miRNAs and their functioning at the synapse in MDD by examining miRNA processing machinery at synapse and sequencing miRNAs and analyzing their functions in synaptic and total tissue fractions obtained from dorsolateral prefrontal cortex (dlPFC) of 15 MDD and 15 matched non-psychiatric control subjects. A total of 333 miRNAs were reliably detected in the total tissue fraction. Multiple testing following the Benjamini-Hochberg false discovery rate [FDR] showed that 18 miRNAs were significantly altered (1 downregulated 4 up and 13 downregulated; p < 0.05) in MDD subjects. Out of 351 miRNAs reliably expressed in the synaptic fraction, 24 were uniquely expressed at synapse. In addition, 8 miRNAs (miR-215-5p, miR-192-5p, miR-202-5p, miR-19b-3p, miR-423-5p, miR-219a-2-3p; miR-511-5p, miR-483-5p showed significant (FDR corrected; p < 0.05) differential regulation in the synaptic fraction from dlPFC of MDD subjects. In vitro transfection studies and gene ontology revealed involvement of these altered miRNAs in synaptic plasticity, nervous system development, and neurogenesis. A shift in expression ratios (synaptic vs. total fraction) of miR-19b-3p, miR-376c-3p, miR-455-3p, and miR-337-3p were also noted in the MDD group. Moreover, an inverse relationship between the expression of precursor (pre-miR-19b-1, pre-miR-199a-1 and pre-miR-199a-2) and mature (miR-19b-3p, miR-199a-3p) miRNAs was found. Although not significantly, several miRNA processing enzymes (DROSHA [95%], DICER [17%], TARBP2 [38%]) showed increased expression patterns in MDD subjects. Our findings provide new insights into the understanding of the regulation of miRNAs at the synapse and their possible roles in MDD pathogenesis.
Insights
Major depressive disorder (MDD) is linked to altered synaptic plasticity and microRNA (miRNA) expression. This study found specific miRNAs are differentially regulated at the synapse in MDD patients, suggesting a role in disease pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Altered synaptic plasticity is a hallmark of major depressive disorder (MDD).
- MicroRNA (miRNA) expression changes are correlated with synaptic function alterations in disease states.
Purpose of the Study:
- To investigate the role of miRNAs and their synaptic regulation in major depressive disorder (MDD).
- To analyze miRNA processing machinery and expression in synaptic and total tissue fractions from the dorsolateral prefrontal cortex (dlPFC) of MDD patients.
Main Methods:
- Sequencing of miRNAs from dlPFC synaptic and total tissue fractions of 15 MDD and 15 control subjects.
- Analysis of miRNA processing enzymes and differential expression using Benjamini-Hochberg false discovery rate (FDR).
- In vitro transfection studies and gene ontology analysis to determine functions of altered miRNAs.
Main Results:
- 18 miRNAs were significantly altered in total tissue, and 8 specific miRNAs showed differential regulation in the synaptic fraction of MDD subjects.
- Altered miRNAs are involved in synaptic plasticity, nervous system development, and neurogenesis.
- Shift in synaptic vs. total fraction expression ratios for several miRNAs and an inverse relationship between precursor and mature miRNA levels were observed.
Conclusions:
- This study reveals novel insights into miRNA regulation at the synapse in the context of MDD.
- Specific synaptic miRNAs are differentially expressed in MDD, implicating them in the disorder's pathogenesis.
- Findings highlight the potential of targeting synaptic miRNAs for MDD treatment.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Depressive Disorders: MDD and Dysthymia
Depression: Overview

